Cardiac Pacing pp 143-146 | Cite as

A Comparative Analysis of the Effect of Glucagon and Atropine in the Sinus and Atrio Ventricular Nodes

  • P. I. Altieri
  • J. M. Toro
  • H. Banch
  • L. del Valle
  • Mary Torres
Conference paper


The drug management of sick sinus syndrome (SSS.) at the present time is not optimal. Due to this we decided to investigate the effect of Atropine (A) and Glucagon (G) in this syndrome. The effect of Glucagon and A in the sinus (SN) and atrioventricular node (A VN) was compared in 11 patients (pts.), 5 with sick sinus syndrome and 6 with normal sinus node function (N) G shortened the sino-atrial recovery time (SART) in N. by 16.6% (1046 ± 112 to 856 ± 61 msec) P < 0.025 and by 23% in SSS (1408 ± 16 to 1058 msec + 110) P < 0.025 A shortened the SART in N by 19.5% (1046 ± 112 to 832 msec + 77) P < 0.025 and by 26.7% in SSS (1335 ± 193 to 945 msec ± 182) P < 0.10. G increased AVN conduction in N by 12% (165 to 141.6 msec ± 34) P < 0.010 and A by 19% (178 ± 27 to 142 msec ± 21) P < 0.0025. The effects in SSS was similar. G increased the heart rate (HR) by 17% in Nand 26% in SSS (NS). A increased the HR by 26% in Nand SSS. In conclusion G and A have similar effects of shortening the SART and increasing A VN conduction, although pts with SSS are more sensitive to both drugs than N. The effect of G lasted up to 5 minutes while A up to 10 minutes. These electrophysiologic findings show that drugs can be used for the temporary management of patients with SSS.


Sinus Node Atrial Pace Atrioventricular Node Atrioventricular Conduction Sick Sinus Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ferrer MI: The sick sinus syndrome. Circulation 1973; 47: 635.CrossRefPubMedGoogle Scholar
  2. 2.
    Engel TR, Schaal SF: Digitalis in the sick sinus syndrome: The effect of Digitalis on sinoatrial automaticity and atrioventricular conduction. Circulation 1973; 48: 1202–1207.CrossRefGoogle Scholar
  3. 3.
    Moss AJ, Davis RJ: Brady-Tachy syndrome. Progress cardiovasc Dis 1974; 16: 439–454.CrossRefGoogle Scholar
  4. 4.
    Simon AB, Zloto AN: Symptomatic sinus node disease: Natural history after permanent ventricular pacing. Pace 1979; 2: 305–314.CrossRefPubMedGoogle Scholar
  5. 5.
    Engel T, Leddy C, González A, Meister S, Frankl WS: Electrophysiologic effect ofhydrazaline on sinoatrial function in patients with sick sinus syndrome. Amer J Cardiol 1978; 41: 763–769.CrossRefPubMedGoogle Scholar
  6. 6.
    Burton G, McCallister BD, Fryerl: Effect of glucagon on resting and exercise hemodynamics in patients with coronary disease. Br Heart J 1972; 34: 924–929.CrossRefGoogle Scholar
  7. 7.
    Lucchesi BR: Cardia actions of glucagon. Circulation Res 1968; 22: 777–787.CrossRefPubMedGoogle Scholar
  8. 8.
    Steiner C, Wit AC, Damato A: Effects of glucagon on atrioventricular conduction and ventricular automaticity in dogs. Circulation 1969; 24: 167–177.CrossRefGoogle Scholar
  9. 9.
    Lucchesi BR, Stutz DR, Winfield RA: Glucagon. Circulation Res 1969; 25: 183–190.CrossRefPubMedGoogle Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt 1983

Authors and Affiliations

  • P. I. Altieri
    • 1
  • J. M. Toro
  • H. Banch
  • L. del Valle
  • Mary Torres
  1. 1.Department of MedicineMedical Science Campus, University of Puerto RicoSan JuanPuerto Rico

Personalised recommendations